Discover an oral immunotherapy option for peanut allergy, now approved for ages 1 through 17 years
Sublingual_Dosing_As_A_Form_Of_Treating_Allergies_In_Patients_c2017-06-20T16:31:28-04:00
Discover an oral immunotherapy option for peanut allergy, now approved for ages 1 through 17 years
Allergenic extracts are indicated for skin test diagnosis and treatment (immunotherapy) of patients with seasonal and perennial allergies.
See the package inserts for the full Prescribing Information for the specific extracts.
Please click here for Package Inserts with full Prescribing Information, including Boxed Warnings.